309 results
Page 7 of 16
6-K
EX-99
f7y0k255qcviqe y0h2
28 Jun 19
BioLineRx Announces Change in Ratio of American
4:01pm
6-K
EX-99
1f5w37
14 May 19
BioLineRx Reports First Quarter 2019 Financial Results
7:00am
6-K
EX-1
5h5 h3mn1whrv
7 May 19
Current report (foreign)
7:00am
6-K
EX-99
1nr3y qxhfiz4z6h
28 Mar 19
BioLineRx Reports Year End 2018 Financial Results
7:00am
6-K
EX-99
5grr 6uu9vz3fw
27 Mar 19
BioLineRx Announces Successful Engraftment Data
7:01am
6-K
EX-99.1
bvnbico7eumo189h3fjp
7 Feb 19
As Representative of the several Underwriters
12:00pm
6-K
EX-99
ht7zw7g7
7 Feb 19
As Representative of the several Underwriters
12:00pm
6-K
EX-99
l3a9zqp8z qexcam3
5 Feb 19
BioLineRx Announces Pricing of $15.4 Million Underwritten Public Offering of its American Depositary Shares and Warrants
9:00am
6-K
EX-99.2
wuru02 7pk
4 Feb 19
Current report (foreign)
4:30pm
6-K
EX-99
slr56krzxp0ovh
4 Feb 19
BioLineRx Receives Orphan Drug Designation from the FDA
7:00am
F-3
p1ol9
26 Dec 18
Shelf registration (foreign)
4:11pm
6-K
EX-99
9zuoiftaol
11 Dec 18
BioLineRx Announces Initiation of Triple Combination Arm of
7:00am
6-K
EX-99
8g0df
20 Nov 18
BioLineRx Announces Receipt of FDA Biological Product
7:00am
6-K
EX-99
ax6v9
8 Nov 18
BioLineRx Reports Significant Progress Across Oncology
7:00am
6-K
EX-99
x9hoz7ye
22 Oct 18
Current report (foreign)
7:00am
6-K
EX-99
dotklhai
19 Oct 18
BioLineRx Presents Top-Line Results from
7:00am
6-K
EX-99.1
1ep1u
3 Oct 18
BioLineRx Increases Stake in BL-8040, its Lead Oncology
6:03am
6-K
EX-99
gv1b 9wwjdo6mdy
13 Aug 18
BioLineRx Reports Second Quarter 2018 Financial Results
7:01am